Pre-exercise participation cardiovascular screening in a heterogeneous cohort of adult cancer patients Journal Article


Authors: Kenjale, A. A.; Hornsby, W. E.; Crowgey, T.; Thomas, S.; Herndon, J. E., 2nd; Khouri, M. G.; Lane, A. R.; Bishop, C. E.; Eves, N. D.; Peppercorn, J.; Douglas, P. S.; Jones, L. W.
Article Title: Pre-exercise participation cardiovascular screening in a heterogeneous cohort of adult cancer patients
Abstract: Background. The purpose of this study was to investigate the extent of pre-exerciseparticipation (“preparticipation”) health screening in a heterogeneous cohort of adult cancer patients. Methods. Patients (n = 413) with histologically confirmed solid or hematologic malignancy were categorized into preparticipation health screening risk stratification based on American College Sports Medicine (ACSM) recommendations. Risk of an exercise-related event was evaluated during a symptom-limited cardiopulmonary exercise test (CPET) with 12-lead electrocardiography (ECG). Results. Participant risk was categorized as low risk (n = 59, 14%), moderate risk (n = 217, 53%), and high risk (n = 137, 33%). Mean peakoxygen consumption was 21.7 6 6.7 mL/kg21 per minute21 or 19.5 6 21.7% below age- and sex-predicted sedentary values. No major serious adverse events or fatal events were observed during CPET procedures. A total of 31 positive ECG tests were observed, for an event rate of 8%. ACSM risk stratification did not predict the risk of a positive test. Age, statin use, antiplatelet therapy use, cardiovascular disease, prior treatment with anthracycline or radiation therapy, and being sedentary were predictors of a positive test (all p < .10). Conclusion. The patient risk-stratification profile strongly suggests that the use of formalized preparticipation health screening is required in all oncology scenarios; however, riskof an exercise-induced event is low, suggesting that the use of exercisetestingis not required for pre-exercise clearance in the majority of patients.
Keywords: oncology; safety; adverse events; cancer; exercise tolerance testing; pre-exercise clearance
Journal Title: The Oncologist
Volume: 19
Issue: 9
ISSN: 1083-7159
Publisher: Oxford University Press  
Date Published: 2014-09-01
Start Page: 999
End Page: 1005
Language: English
DOI: 10.1634/theoncologist.2014-0078
PROVIDER: scopus
PMCID: PMC4153462
PUBMED: 25061091
DOI/URL:
Notes: Export Date: 1 October 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lee Winston Jones
    178 Jones